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Abstract
In cells the breakdown of arginine to ornithine, ammonium ion plus carbon dioxide is coupled to the 
generation of metabolic energy in the form of ATP. The arginine breakdown pathway is minimally 
composed of arginine deiminase, ornithine transcarbamoylase, carbamate kinase and an 
arginine/ornithine antiporter; ammonia and carbon dioxide most likely diffuse passively across the 
membrane. The genes for the enzymes and transporter have been cloned and expressed and the 
proteins have been purified from Lactococcus lactis IL1403 and incorporated into lipid vesicles for 
sustained production of ATP. Here, we study the kinetic parameters and biochemical properties of the 
individual enzymes and the antiporter, and we determine how the physicochemical conditions, 
effector composition and effector concentration affect the enzymes. We report the KM and VMAX 
values for catalysis and the native oligomeric state of all proteins, and we measured the effect of 
pathway intermediates, pH, temperature, freeze-thaw cycles and salts on the activity of the cytosolic 
enzymes. We also present data on the protein-to-lipid ratio and lipid composition dependence of the 
antiporter.
Introduction
The arginine deiminase pathway is one of the simplest routes for the generation of ATP and 
alkalinization of the internal pH. With only three cytosolic enzymes, arginine is converted into 
ornithine, ammonium ion plus carbon dioxide, while ATP is created from ADP and phosphate (Fig. 
1); the reaction equation is: 
L-Arginine + H2O + HPO42- + Mg-ADP1- + 3H+ → L-Ornithine + Mg-ATP2- + 2NH4+ + CO2
The enzymes of the pathway are arginine deiminase (ADI), which hydrolyzes arginine into citrulline 
plus ammonium ion; ornithine transcarbamoylase (OTC), which converts citrulline plus phosphate 
into carbamoyl-phosphate (carbamoyl-Pi) plus ornithine; and carbamate kinase (CK), which 
hydrolyzes carbamoyl-Pi to form carbon dioxide plus ammonium ion under concomitant formation of 
ATP from ADP and the phosphate moiety of carbamoyl-Pi. The ADI pathway also employs a 
membrane-bound arginine/ornithine antiporter (AOA) to couple the import of the substrate arginine to 
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The ADI pathway is widely used in bacteria to generate metabolic energy [1,2] and to protect cells in 
acidic environments [3,4]; per molecule of arginine metabolized three protons are used (see reaction 
equation). The enzymes of the pathway are also found in archaea [5], lower eukaryotes [6] and some 
are also present in mammalian cells (based on our own genome searches). In some protozoa, the 
pathway is used for energy generation [7,8] but is also important for pathogenesis [9,10]. By secreting 
ADI and OTC into the external medium, the concurrent depletion of arginine reduces the production 
of antiparasitic (and antimicrobial) nitric oxide in infected tissues [9,10]. Some bacteria have an 
anabolic OTC in addition to the catabolic one, which is used for arginine biosynthesis instead of 
arginine breakdown [11]. Interestingly, a catabolic OTC can be changed into an anabolic OTC with 
only one mutation [11]. The anabolic OTCs have a strongly reduced cooperativity and lower apparent 
KM for carbamoyl-Pi. In mammalian cells arginine metabolism is rather complex, as arginine is 
involved in synthesis of proteins, urea, creatine, polyamines, nitric oxide, proline, glutamate and 
agmatine [12]. Mammalian cells use arginases that catalyze the reaction of arginine plus water into 
ornithine plus urea, and they have anabolic but not catabolic OTCs [13]. Furthermore, mammalian 
cells do not use CKs but have AOAs in their mitochondria and make use of arginine uniporters 
[14,15].
The proteins for breakdown of arginine are encoded by arcA (ADI), arcB (OTC), arcC (CK) and 
arcD (AOA), and in bacteria they are usually present in a gene cluster [16], although the arrangement 
of the genes varies between species. In archaea the proteins have been found in a gene cluster but also 
dispersed over the chromosome [16]. The arc operon in Lactococcus lactis contains two copies of 
arcC and arcD (due to gene duplication) as well as arcT, a putative amino acid transaminase [17] and 
argS, an arginine-tRNA ligase [18,19]. Additionally, the transcription factor argR and an sRNA 
(argX) are located upstream of the arc operon, which are arginine-dependent regulators of the 
pathway [20,21]. The arc operon is further regulated by the transcription factors CcpA and AhrC, 
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Individual enzymes for arginine breakdown have been studied, but to our knowledge a comprehensive 
and systematic characterization of all enzymes from a single organism has not been carried out. One 
study characterizes ADI and CK from Streptococcus pyogenes [23], while three separate studies 
report on ADI, OTC and CK from Giardia lamblia [24–26]. In addition, ADI and OTC from 
Pseudomonas aeruginosa have been studied [11,27], as well as OTC and CK from Enterococcus 
faecalis [28–30] and from Pyrococcus furiosus [31,32]. Other studies focus on individual enzymes 
(e.g. [33]). Arginine/ornithine antiport activity was first studied in L. lactis, both in membrane 
vesicles [34] and in whole cells [35]. Later it was shown in whole cells that L. lactis has two AOAs, 
namely ArcD1 and ArcD2, which have a similar affinity for arginine but very different affinities for 
ornithine, lysine, histidine and alanine [36]. The archaeal ArcD antiporter from Halobacterium 
salinarum has been studied in membrane vesicles, which showed a similar KM but a lower specific 
activity for arginine than the protein from L. lactis [37]. 
Recently, we used ArcA, ArcB, ArcC1 and ArcD2 from L. lactis to construct an ATP-regenerating 
system in synthetic vesicles [38]. The system is fed with external arginine and can maintain constant 
levels of ATP for up to at least 6 hours, even when ATP is consumed. The produced ATP has been 
used to fuel the gated transport of an osmolyte, which allows the vesicles to respond to osmotic stress. 
We now characterize ArcA, ArcB, ArcC1 and ArcD2 from L. lactis IL1403; we determined the 
oligomeric state and kinetic parameters of enzymatic conversion or transport of the purified proteins, 
determined the pH and temperature dependence of the enzymes, and the role of small molecule 
effectors on their catalytic performance.
Results
Choice of the proteins for arginine breakdown. We have studied ArcA, ArcB, ArcC1 and ArcD2 
from Lactococcus lactis IL1403. We chose to work with ArcC1, as initial expression tests showed 
better production of ArcC1 than ArcC2. We had to work with ArcD2 as ArcD1 from L. lactis IL1403 
misses the 14th transmembrane helix when aligned to ArcD1 from L. lactis MG1363 [39], rendering 
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coefficient, isoelectric point (pI), molecular weights (MW) and oligomeric state, are summarized in 
Table 1. 
Expression and purification of proteins. ArcA, ArcB, ArcC1 and ArcD2 from L. lactis IL1403 were 
expressed in L. lactis NZ9000 (cytosolic proteins) or JP9000 (ArcD2), as described in [38]. The 
proteins were purified with metal-affinity chromatography, followed by size-exclusion 
chromatography, which resulted in single bands on a SDS-PAA gel (Fig. 2A). The molecular weights 
of the SDS-denatured proteins matched well with the theoretical monomeric molecular weights 
(ArcA: 47.7 kDa, ArcB: 40.9 kDa, ArcC1: 36.2 kDa and ArcD2: 56.7 kDa), except for ArcD2, which 
migrates at a lower molecular weight than expected. This has been observed for many other 
membrane proteins and is probably due to incomplete denaturation by SDS [40]. 
Oligomeric state analysis. We have determined the oligomeric state of the proteins by coupling size-
exclusion chromatography to multi-angular light scattering (SEC-MALS), of which the 
chromatograms are shown in Fig. 2B. SEC-MALS determines the absolute molar mass and average 
size of a protein by detecting how it scatters light. For ArcA, we found a native molecular weight of 
194 kDa, indicating a tetrameric oligomeric state. The native molecular weight of ArcA from L. lactis 
ATCC 7962 (which has 100 % identity with the ArcA studied here) was measured before by [33]. 
They found by size-exclusion chromatography a native molecular weight of 140 kDa and concluded 
that the protein is a trimer. We obtained the same molecular weight in our size-exclusion 
chromatography analysis (data not shown), but find a higher native molecular weight when the multi-
angular light scattering is included in the analysis. In general, SEC-MALS is the method of choice to 
analyze the oligomeric states of proteins, as it allows correcting for differences in shape and e.g. the 
presence of bound detergent in case of membrane proteins [41]. A structural study on arginine 
deiminase from Streptococcus pyogenes (44.5 % amino acid identity with L. lactis ArcA) showed a 
mix of monomeric and dimeric states [42], while the protein from Pseudomonas aeruginosa (32.1 % 
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The native molecular weight of ArcB was 245 kDa, indicating a hexameric state. Ornithine 
transcarbamoylase from Lactobacillus hilgardii (69.8 % identity with L. lactis ArcB) and Gloeobacter 
violaceus (35.9 % identity) were also found to be hexamers [44,45]. For ArC1 we found a native 
molecular weight of 73 kDa, which corresponds to a dimer. Carbamate kinase from Enterococcus 
faecalis (48.4 % identity with L. lactis ArcC1) and Pyrococcus furiosus (42.6 % identity) both 
showed a dimeric state [32,46]. Finally, we found a native molecular weight of 53 kDa for ArcD2, 
which indicates that the arginine/ornithine transporter is monomeric, that is, at least in the DDM-
solubilized state. The arginine/agmatine antiporter AdiC from Escherichia coli (22.5 % amino acid 
identity with L. lactis ArcD2), which belongs to the same amino acid/polyamine/organocation 
superfamily of transporters as ArcD2, was found to be a dimer [47]. 
When analyzing the protein database (PDB) structures of Arc homologs with bound substrates (e.g. 
ADI from Pseudomonas aeruginosa, 32 % identity with L. lactis ArcA, PDB ID: 1LXY; OTC from 
Vibrio vulnificus, 48 % identity with L. lactis ArcB, PDB ID: 4H31; CK from E. faecalis, 52 % 
identity with L. lactis ArcC1, 2WE5), we find that the proteins have one active site per monomer 
[46,48,49]. Therefore the kcat values were calculated with the assumption that every monomer is 
catalytically active.
Characterization of arginine deiminase. We first determined the kinetic parameters of L. lactis 
IL1403 ArcA, using arginine as the substrate (Fig. 3A). The Michaelis-Menten fit of the datapoints is 
shown in Fig. 3B, giving a KM value of 34.5 ± 6.6 µM and a VMAX of 4.2 ± 0.2 µmol min-1 mg-1 at 30 
°C in 50 mM KPi, pH 7.0. The kcat was calculated at 3.3 ± 0.2 s-1, with the assumption of one active 
site per monomer, hence four sites per tetramer. When the concentration of arginine is increased 
beyond 0.5 mM, substrate inhibition is observed with a KI of 3.2 mM (Fig. 3C). An earlier study on 
ArcA from L. lactis ATCC 7962 (100 % amino acid identity with L. lactis IL1403 ArcA) reported a 
KM of 8.7 ± 0.05 mM and a VMAX of 345 ± 2 µmol min-1 mg-1 at 60 °C in 100 mM KPi, pH 7.2 [33]. 
These VMAX and KM values are approximately two orders of magnitude higher than the ones we 
found, but also much higher when compared to ArcA from other organisms in the BRENDA database 
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temperature at which the ATCC 7962 enzyme was assayed (60 °C versus 30 °C), but intriguingly the 
ATCC 7962 and IL1403 ArcA proteins also differ in temperature dependence (see below). 
Kim et al. measured citrulline production like we did via the reaction with 2,3-butanedione monoxime 
(DAMO), but they did not use a reducing agent (thiosemicarbazide in our assay) or an iron catalyst 
(we use ammonium iron(III) sulfate) [33,50]. The ratio between reaction and acid mixture is also 
different, where we add 150 µL of a 3:2:5 mixture (v/v) of 95 % H2SO4, 85 % H3PO4 and H2O to 50 
µL of reaction mix, Kim et al. adds 250 µL of a 1:3 mixture (v/v) of 95 % H2SO4 and 85 % H3PO4 to 
500 µL of reaction mix [33]. Finally, the concentration of DAMO is very different, as we use about 
0.16 % (w/v), while the previous study uses 0.75 %. We therefore think that their assay is less 
sensitive to citrulline production than the assay that we used. This could explain why they used 10 
mM arginine as the lowest concentration, even though it is higher than the KM of 8.7 mM that they 
report for arginine.
Next we investigated the effect of ADI pathway intermediates on the activity of ArcA. The addition 
of up to 10 mM carbamoyl-Pi did not influence the activity of ArcA (Fig. 3D, green bars), while 10 
mM ornithine (20 times in excess of arginine) decreased the activity by 30 % (Fig. 3D, blue bars). 
The inhibition by ornithine is most likely competitive in nature as the amino acid may fit in the same 
binding pocket as arginine. Carbamoyl-Pi, on the other hand, is structurally very different and will 
most likely not compete with arginine for binding to ArcA. Mg-ATP, Mg-ADP, Mg-AMP or 
ammonia at a concentration of 2 mM did not affect the activity of ArcA, but 20 mM of ammonia 
decreased activity by 30 % (data not shown).
The optimum pH of ArcA is pH 7.2 at 30 °C (Fig. 3E, left), while the optimum temperature is 41 °C 
at pH 7.0 (Fig. 3E, middle). Between pH 6.8 and 7.2, the change in activity is small, but lowering the 
pH to 5.8 decreases activity by 14 %, while increasing the pH to 8 drops activity by 30 %. When the 
temperature of the reaction mix was increased from 26 °C to 41 °C, the activity of ArcA increased. 
Any further increase in temperature led to a decrease in activity and full inactivation was seen at 62 
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study of Kim et al. the enzyme was completely inactive at pH 6.4 or 7.8 [33]. Additionally, Kim et al. 
found an optimal temperature of 60 °C and a decrease of 85 % in activity at 40 °C, which is almost 
the opposite effect of what we observe here [33]. They observed inactivation of the enzyme at 60 °C 
in about 40 min, while we see that ArcA is completely inactivated within 3 minutes (Fig. 3E, middle). 
We have no explanation for the discrepancy between the studies of Kim et al. and ours [33].
Freezing the enzyme in liquid nitrogen and subsequently thawing it has little or no effect on ArcA 
activity (Fig. 3E, right). This finding is important for studies where the enzyme has to be stored or 
encapsulated into synthetic vesicles, as described by [38]. Finally, increasing the concentration of 
potassium phosphate (KPi) does not have an effect on ArcA activity (Fig. 3F, blue bars). Changing to 
sodium phosphate (NaPi) and increasing its concentration to 100 mM or higher seems to increase 
ArcA activity, although the error of the measurements was relatively large (Fig. 3F, green bars). 
Adding 50 mM of potassium chloride (KCl) or sodium chloride (NaCl) to 50 mM KPi had some 
effect (Fig. 3F, pink and yellow bars), but overall ArcA is not very sensitive to changes in ionic 
strength. Changing from a phosphate buffer to Tris-HCl reduced activity by 90 % (Fig. 3F, light blue 
bars).
Characterization of ornithine transcarbamoylase. The kinetic parameters of L. lactis IL1403 ArcB 
were characterized with ornithine and carbamoyl-Pi as substrates (Fig. 4A). In the breakdown of 
arginine, this reaction runs in the opposite direction, but the equilibrium constant (Keq) favors 
formation of citrulline plus inorganic phosphate by a factor of ~ 105. The forward reaction has been 
studied for ArcB from E. coli, using arsenate instead of phosphate, yielding the formation of ornithine 
plus carbamoyl-arsenate [51]; the latter decomposes spontaneously into carbon dioxide, ammonium 
ion and arsenate. The Michaelis-Menten fits of the datapoints of Fig. 4B yield a KM value of 0.7 ± 0.2 
mM and a VMAX of 600 ± 40 µmol min-1 mg-1 for ornithine (left panel), when the concentration of 
carbamoyl-Pi is kept at 5 mM. When the concentration of carbamoyl-Pi is varied, we obtain a KM of 
2.7 ± 0.4 mM and a VMAX of 830 ± 65 µmol min-1 mg-1 (right panel), with the concentration of 
ornithine fixed at 5 mM. The kcat values are 410 ± 30 s-1 and 565 ± 45 s-1 for ornithine and carbamoyl-
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other ArcB-like enzymes in the BRENDA database, we find that the KM for carbamoyl-Pi is the 
highest, while the KM for ornithine is one of the lowest; our kcat values are among the highest reported 
so far.
With 10 mM of arginine (2 times more than the concentrations of ornithine and carbamoyl-Pi) the 
activity of ArcB decreased by 25 %, (Fig. 4C). Like the inhibition of ArcA by ornithine, ArcB may be 
inhibited by arginine because it is structurally similar to ornithine. The addition of 2 mM Mg-ATP, 
Mg-ADP, Mg-AMP or 20 mM ammonia had no effect on ArcB (data not shown). The optimum pH of 
ArcB was pH 7.5 at 30 °C (Fig. 4D, left) and the optimum temperature was 35 °C at pH 7.0 (Fig. 4D, 
middle). Lowering of the pH from 7.0 to 5.8 inactivated the enzyme for more than 90 %, while 
increasing the pH to 8.0 reduced the activity by 25 %. Lowering the temperature from 35 to 25 °C 
lowered activity by 75 %, while increasing the temperature to 62 °C inactivated ArcB, similar to what 
we observed for ArcA.
We find that ArcB in solution is sensitive to cycles of freezing and thawing (FT) (Fig. 4D, right). 
After just one FT cycle, we observed an 80 % loss in activity. To check if this inactivation also 
happens when ArcB is encapsulated in vesicles (as done in [38]), we mimicked those conditions by 
adding ArcD2 proteoliposomes, Mg-ADP and ornithine to the FT mix; we omitted ArcA and ArcC1 
to be able to measure ArcB activity. After a varying number of cycles of freezing and thawing, the 
vesicles were dissolved with 0.1 % (v/v) Triton X-100 and ArcB activity was determined. 
Importantly, ArcB in the vesicles was much less affected by freezing and thawing, as a loss of activity 
of only 25 % was observed after five FT cycles. Most likely the encapsulation of ArcB in the vesicles 
and the presence of the substrate (ornithine) stabilizes the enzyme.
Increasing the concentration of KPi or NaPi decreased the activity of ArcB, probably because the 
reactant inorganic phosphate becomes inhibitory (Fig. 4E, blue and green bars). This notion is 
supported by the finding that increasing the salt concentration (addition of KCl) did not inhibit the 
enzyme. In fact, concentrations of KCl above 50 mM increased the activity of ArcB (Fig. 4E, pink 
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Characterization of carbamate kinase. We used carbamoyl-Pi and Mg-ADP as substrates to 
determine the kinetic parameters of the reaction catalyzed by ArcC1 from L. lactis IL1403 (Fig. 5A). 
The Michaelis-Menten fits of the datapoints of Fig. 5B give a KM value of 0.6 ± 0.2 mM and a VMAX 
of 330 ± 30 µmol min-1 mg-1 for carbamoyl-Pi (left panel), when the concentration of Mg-ADP is 
fixed at 5 mM. For Mg-ADP, a KM of 1.6 ± 0.7 mM and a VMAX of 310 ± 40 µmol min-1 mg-1 were 
determined (right panel), when carbamoyl-Pi is kept constant at 5 mM. The kcat values of ArcC1 are 
200 ± 20 s-1 and 190 ± 15 s-1 when carbamoyl-Pi and Mg-ADP are varied, respectively, assuming one 
active site per monomer. The error bars in Fig. 5B are relatively large, as the data was obtained from 
the combination of two independent ratiometric fluorescent measurements, using PercevalHR for 
determination of the ATP/ADP ratio and pyranine for pH. Because the PercevalHR readout is 
sensitive to pH (see [38,52]), we used the pyranine data to correct the Perceval HR fluorescence for 
the increase in pH. According to the BRENDA database very few ArcC-type enzymes have been 
studied. The kcat values reported here for ArcC1 are the highest reported up to now.
Adding up to 10 mM of arginine did not negatively affect the activity of ArcC1 (Fig. 5C, blue bars). 
Citrulline at 10 mM decreased the activity by 40 to 50 % (Fig. 5C, green bars), while ornithine was 
slightly inhibitory (Fig. 5C, pink bars). The optimum pH for ArcC1 activity is 7.0 at 30 °C (Fig. 5D, 
left), while the optimum temperature is 25 °C at pH 7.0 (Fig. 5D, middle). The enzyme has a narrow 
pH window for its activity, as ArcC1 is fully inactivated below pH 5.8 or above pH 8.0. ArcC1 is also 
much more sensitive to temperature than ArcA and ArcB. Freeze-thaw cycles, on the other hand, had 
little influence on the activity of ArcC1 (Fig. 5D, right). 
KPi and NaPi decreased the activity of ArcC1 when their concentrations were above 50 mM (Fig. 5E, 
blue and green bars). The inhibition by increasing NaPi or KPi concentration may reflect competitive 
inhibition as inorganic phosphate may compete with carbamoyl-Pi for binding to ArcC1. 
Interestingly, NaPi inhibits the activity of ArcC1 more than KPi does, an effect that is also seen when 
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and yellow bars). As observed for ArcA and ArcB, Tris-HCl inhibited ArcC1 at concentrations above 
50 mM (Fig. 5E, light blue bars). 
Characterization of the arginine/ornithine antiporter. The kinetic parameters of ArcD2 from L. 
lactis IL1403 were determined in proteoliposomes with external arginine as substrate and internal 
ornithine or citrulline as counter-substrate for the antiport reaction (Fig. 6A). The standard 
proteoliposomes consisted of 50 mole% 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), 38 
mole% 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DOPG) and 12 mole% 1,2-dioleoyl-sn-
glycero-3-phosphocholine (DOPC). The Michaelis-Menten fits of arginine/ornithine antiport are 
shown in Fig. 6B, giving a KM value of 6.0 ± 0.7 µM and a VMAX of 120 ± 5 nmol min-1 mg-1 for 
external arginine (left panel) when 10 mM of ornithine is present on the inside. Additionally, a KM of 
2.5 ± 0.7 mM and a VMAX of 95 ± 10 nmol min-1 mg-1 were obtained for internal ornithine and 25 µM 
of arginine on the outside (right panel). The kcat values are 0.11 ± 0.005 s-1 and 0.09 ± 0.009 s-1 when 
arginine and ornithine, respectively, were varied in the kinetic analysis. Previously, ArcD2 was 
studied in whole cells [36], who found a KM of 4 ± 2 µM and a VMAX of 22 ± 17 nmol min-1 mg-1 for 
external arginine. Surprisingly, Noens et al. found a 5 to 6-fold higher VMAX for ornithine/ornithine 
than for arginine/ornithine antiport [36]. It is possible that the different lipid composition, varying 
internal substrate concentration(s) or the presence of additional arginine and/or ornithine transporters 
have affected the whole cell measurements. We therefore do not further compare our measurements 
with those in intact cells.
Next, we characterized ArcD2-mediated arginine/citrulline antiport. Without a membrane potential 
(ΔΨ), no arginine/citrulline antiport was observed, even with 20 mM internal citrulline (Fig. 6C, 
green circles). When a ΔΨ of -120 mV was applied (by diluting the KPi-filled proteoliposomes 100-
fold into NaPi plus valinomycin; see Materials & Methods), we observed transport. We determined a 
KM of 6.0 ± 2.1 mM and a VMAX of 20 ± 3 nmol min-1 mg-1 when internal citrulline was varied with 
25 µM arginine on the outside (Fig. 6C, blue squares). For arginine/ornithine antiport we do not 
observe an effect of imposing a ΔΨ (see [38]). The KM values for internal ornithine and citrulline are 
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than the one found for arginine/ornithine antiport; in the absence of a ΔΨ the VMAX the 
arginine/citrulline antiport is below our detection limit. The stimulation of arginine/citrulline antiport 
by a membrane potential inside negative is in accordance with the difference in charge of arginine 
(cationic) and citrulline (neutral); hence this translocation cycle is electrogenic.
We tested the activity of ArcD2 at protein-to-lipid ratios (w/w) of 1:800, 1:400, 1:200 and 1:100 (Fig. 
6D, left). The highest uptake rate was observed at a ratio of 1:200 but the highest specific activity was 
found at 1:800, that is, when we assume that equal fractions of ArcD2 are reconstituted at each 
protein-to-lipid ratio. Next, we varied the amount of DOPG (and inversely DOPC) while keeping 
DOPE constant (Fig. 6D, middle). The extremes of 50 mole% DOPG and 0 mole% DOPG (and thus 0 
mole% DOPC and 50 mole% DOPC, respectively) lowered the activity by 80 to 90 %. Lowering the 
concentration of DOPG from 38 mole% to 25 or 13 mole% however increased the activity by 30 and 
60 %. Finally, we replaced one of the dioleoyl tails by a palmitoyl tail in the lipid mixture with 38 
mole% of PG, 12 mole% PC plus 50 mole% PE. Surprisingly, we find that the activity of ArcD2 in 
POPX lipids is reduced by 60 % when compared to DOPX (Fig. 6D, right). Thus, the increased 
packing and presumably lower fluidity of membranes composed of POPX lipids reduce the activity of 
the ArcD2 transporter [53,54]. We recently made the opposite observation for an eukaryotic amino 
acid transporter [55].
It has been reported that (small) peptides rich in arginine permeate lipid membranes without the need 
for a membrane protein [56,57]. This prompted us to study the passive influx of arginine into vesicles 
with and without ArcD2 (Fig. 6E) and thus discriminate passive influx from carrier-mediated uniport. 
Empty ArcD2 proteoliposomes were incubated with 1 µM of radiolabeled arginine for one hour, 
which shows very slow uptake at a rate of about 0.09 nmol min-1 mg-1. The same experiment was also 
performed with liposomes without ArcD2, which showed no arginine uptake at all (data not shown). 
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Finally, we determined how long an artificially imposed membrane potential (ΔΨ) lasts in vesicles 
composed of 38 mole% DOPG, 12 mole% DOPC plus 50 mole% DOPE (Fig. 6F). We diluted ArcD2 
proteoliposomes, filled with 10 mM citrulline and 50 mM KPi pH 7.0, into 50 mM NaPi pH 7.0 with 
valinomycin (see Materials & Methods), and after 0, 10, 20, 30, 45 and 60 minutes we added 
radiolabeled arginine. Fig. 6C shows arginine/citrulline antiport only when a ΔΨ is present. We find 
the highest rate of transport when uptake of arginine is assayed from the moment the membrane 
potential is imposed. As expected the rate decreases at later times, which reflects the transient nature 
of the ΔΨ. The membrane potential is maintained for at least 60 minutes (albeit at a lower value than 
initially) when the proteoliposomes are osmotically shocked by addition of 250 mM NaCl (Fig. 6F, 
blue squares). In the unshocked condition, the ΔΨ drops to zero within 60 minutes (Fig. 6F, green 
circles).
Discussion
We report the characterization of the enzymes and transporter responsible for breakdown of arginine 
and production of ATP from a single organism. As presented in the introduction, this pathway has 
recently been incorporated into lipid vesicles to form an ATP-regenerating system that can perform 
long-term energy homeostasis [38]. We find that the import of arginine into cells or vesicles by 
ArcD2 and the concomitant export of the product of arginine breakdown, that is ornithine, is 
relatively slow and presumably rate-determining for the production of ATP. The kcat of ArcD2 is more 
than an order of magnitude lower than that of the slowest enzyme, and the maximal rate of 
arginine/ornithine transport is reached at a concentration of about 60 µM (KM = 6.0 µM). ArcA or 
ArcB may catalyze the second slowest step. ArcA has a lower kcat than ArcB, but the latter enzyme 
was assayed in the backward reaction; the forward reaction requires a high concentration of citrulline 
plus inorganic phosphate and a low concentration of ornithine and carbamoyl-Pi. The high kcat of 
ArcC1 ensures that carbamoyl-Pi is rapidly converted into ammonia plus carbon dioxide (with 
concomitant production of ATP from ADP). 
One of the first improvements for the ATP-regenerating system in synthetic vesicles would thus be to 
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increase in kcat. ArcD2 is a well-coupled antiporter, as arginine uniport occurs at less than 1 % of the 
arginine/ornithine antiport activity. The protein also mediates arginine/citrulline antiport, but this 
activity is very low in the absence of a membrane potential. These two qualities are important to keep 
in mind and to test for when looking for alternative arginine/ornithine antiporters.
The enzymes of the pathway are not very sensitive to pathway intermediates, albeit that some 
inhibition by inorganic phosphate of the backward reaction of ArcB and the forward reaction of 
ArcC1 is observed. The inhibition of ArcB will however not pose a problem for the breakdown of 
arginine, because the inorganic phosphate is used as a substrate in the forward reaction of ArcB. The 
pH and temperature ranges in which the system work optimally are quite narrow, as the activity of the 
enzymes (in particular of ArcC1) is strongly decreased when deviating from pH 7.0 and 30 °C. A 
second improvement to the ATP-regenerating system would be to use a more robust carbamate 
kinase, that is, an enzyme that is influenced less by pH and temperature.  
The freeze-thaw cycles needed for inclusion of the enzymes into vesicles and future synthetic cells do 
not have significant adverse effects on the reconstitution of the arginine breakdown pathway. This is 
an important finding, as the freeze-thaw cycles are an essential step in the creation of synthetic cell 
like systems. Furthermore, the enzymes work well in phosphate buffers with potassium or sodium as 
the counter ion, which are physiological conditions. 
The enzymes characterized in this paper have been coupled to ATP consumption by reconstituting the 
metabolic network with the ATP-dependent glycine betaine importer OpuA [38]. We have observed 
that without ATP consumption, the ATP/ADP ratio increases until all ADP is consumed. The full 
pathway then stops but surprisingly arginine uptake and deamination continues, leading to a futile 
cycle with acidification of the interior of the cell. With OpuA activity present, the full pathway 
continues with limited futile hydrolysis of arginine and the ATP/ADP ratio stays constant for several 
hours. Thus, adding an ATP consuming reaction leads to greater stability (and basic homeostasis) of 










This article is protected by copyright. All rights reserved
Materials and Methods
Materials. Common chemicals were of analytical grade and ordered from Sigma-Aldrich 
Corporation, Carl Roth GmbH & Co. KG or Merck KGaA. The lipids were obtained from Avanti 
Polar Lipids, Inc. (>99 % pure, in chloroform): 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine 
(DOPE) [850725C], 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) [850375C], 1,2-dioleoyl-sn-
glycero-3-phospho-(1'-rac-glycerol) (DOPG) [840475C], 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoethanolamine (POPE) [850757C], 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
(POPC) [850457C] and 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (POPG) 
[840457C]. n-dodecyl-β-D-maltoside (DDM) [D97002] was purchased from Glycon Biochemicals 
GmbH and Triton X-100 [T9284] from Sigma-Aldrich Corporation. 14C-L-arginine was purchased 
from Moravek, Inc. [MC-137, 338 mCi mmol-1].
Expression and purification of proteins. The construction of strains used for expression of ArcA, 
ArcB, ArcC1 and ArcD2 has been described in [38], together with the methods for expression, 
purification and storage of the proteins. For the characterization of ArcD2, reconstitution was done as 
described for the 14C-L-arginine transport assays.
Protein purity and concentration determination. Protein purity was determined with SDS-PAGE, 
using a 4 % stacking gel and 12.5 % separating gel, as described in [58]. ArcA, ArcB and ArcC1 were 
purified in 50 mM KPi, pH 7.0 with 200 mM NaCl [plus 10 % (v/v) glycerol for ArcC1] at 
concentrations between 4 and 8 mg mL-1 and stored in 50 mM KPi, pH 7.0 with 100 mM NaCl [plus 
10 % (v/v) glycerol for ArcC1] at -80 °C. ArcD2 was purified in 50 mM KPi, pH 7.0 with 200 mM 
KCl plus 0.02 % (w/v) n-dodecyl-β-D-maltoside and reconstituted into preformed liposomes (for lipid 
composition see below, Table 2). ArcD2 proteoliposomes were stored in 50 mM KPi, pH 7.0 in liquid 
nitrogen. Cell lysate at 10 mg/ml and Ni2+-Sepharose resin flow through fractions were diluted 15-
fold, Ni2+-Sepharose resin wash fractions were diluted 1.25-fold and protein fractions were diluted to 
0.2 mg mL-1 with loading buffer (final concentrations: 2 % (v/v) SDS, 4 % glycerol, 0.01 % 
bromophenol blue plus 5 % β-mercaptoethanol in 50 mM Tris-HCl, pH 6.8). Protein gels were stained 
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coefficient and the absorbance at 280 nm, measured with a microvolume UV-Vis spectrophotometer 
(NanoDrop Technologies, Inc.). 
Oligomeric state of proteins. Ni2+-Sepharose/size-exclusion chromatography-purified fractions of 
ArcA, ArcB, ArcC1 and ArcD2 were analyzed on a second Superdex 200 Increase 10/300 GL size-
exclusion column (GE Healthcare) in 50 mM KPi, pH 7.0 plus 100 mM NaCl [with 0.02 % (w/v) 
DDM for ArcD2], which was coupled to a multi-angle light scattering system with detectors for 
absorbance at 280 nm (Agilent Technologies, Inc.), static light scattering (Wyatt Technology 
Corporation) and differential refractive index (Wyatt Technology Corporation). Data analysis was 
performed with the ASTRA software package (Wyatt Technology Corporation), using a value for the 
refractive index increment (dn/dc)protein of 0.180 mL mg-1 and (dn/dc)detergent of 0.143 mL mg-1 [41]. 
We calibrated the detectors with BSA for ArcA, ArcB and ArcC1 and with aldolase for ArcD2 (Fig. 
8).
Enzymatic assays for ArcA and ArcB. Activity of ArcA and ArcB was measured with the 
COLDER assay, originally described in [50]. The values for KM and VMAX data were obtained as 
described in [38]. Briefly, either 2 µg mL-1 ArcA or 0.25 µg mL-1 ArcB was incubated in 50 mM KPi, 
pH 7.0 at 30 °C for 3 min in a total volume of 275 µL. To start the reaction, varying concentrations of 
either 0 to 480 µM L-arginine for ArcA, or 0 to 10 mM L-ornithine plus 0 to 5 mM carbamoyl-Pi for 
ArcB were added and citrulline formation was analyzed every 30 sec over a 2.5 min period. 200 µL of 
COLDER solution (20 mM 2,3-butanedione monoxime (DAMO), 0.5 mM thiosemicarbazide, 2.25 M 
phosphoric acid, 4.5 M sulfuric acid plus 1.5 mM ammonium iron(III) sulfate) was pipetted into each 
well of a 96-well flat-bottom transparent polystyrene plate (Greiner Bio-One International GmbH), to 
which 50 µL of reaction mixture was added to stop the enzymatic conversion. Additionally, a set of 
calibration samples with L-citrulline concentrations ranging from 0 to 250 µM was added to the 
COLDER solution. To allow color development, the plate was sealed with thermo resistant tape 
(Nalge Nunc International) and incubated at 80 °C for 20 min in a block heater (Stuart). Afterwards, 
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1000 x g, 20 °C) and the absorbance was measured at 540 nm in a plate reader (BioTek Instruments, 





cenz ∗  volrm
where Δenz (AU min-1) and Δcal (AU x nmol L-citrulline-1) are the slopes of the enzyme and 
calibration curves, respectively; cenz is the final concentration of enzyme in mg mL-1 and volrm is the 
volume of the reaction mixture in mL.
After plotting the enzyme activities (reaction rates) at various concentrations of substrate, the 
datapoints were fitted with the Michaelis-Menten equation:
(2)𝑣 =
VMAX ∗  [S]
KM +  [S]
where v is the reaction rate, VMAX is the maximum reaction rate, KM is the Michaelis constant and [S] 
is the substrate concentration. In addition, we used the Michaelis-Menten equation with uncompetitive 
inhibition to fit the substrate inhibition of ArcA, for which we modified equation 2 as follows:
(3)𝑣 =
VMAX ∗  [S]
KM +  α ∗  [S]
where α is defined as:
(4)α = 1 +
[I]
KI
where [I] is the apparent inhibitor concentration and KI is the inhibition constant.
To determine the pH and temperature dependence, as well as the role of small molecule effectors, 
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mM L-ornithine plus 5 mM carbamoyl-Pi for ArcB as the substrates and with the following 
adjustments. For the experiments with ADI pathway intermediates, 0 to 10 mM of L-ornithine, 
carbamoyl-Pi or L-arginine were added to the reaction mixtures. To determine the pH dependence of 
the enzymes, the 50 mM KPi buffer in the reaction mixture was adjusted to a pH between 5.8 and 8.0 
by mixing the appropriate amounts of KH2PO4 and K2HPO4. To determine the temperature 
dependence of the enzymes, the reaction mixture was incubated between 26 °C and 62 °C. To 
determine the effect of freeze-thaw cycles on the enzymes, the protein stocks (4.2 to 7.2 mg of protein 
mL-1) were either not frozen (control sample) or frozen in liquid nitrogen and thawed in an ice-water 
bath at 10 °C; the freeze-thaw cycles were repeated up to 8 times prior to determining the enzymatic 
activity. Alternatively, 2 µM ArcB was encapsulated into ArcD2 proteoliposomes (66 µL, 6.6 mg of 
lipid) with 5 mM Mg-ADP (MgSO4 plus ADP) and 0.5 mM L-ornithine in 50 mM KPi, pH 7.0, the 
samples were frozen and thawed 0 to 5 times. Next, the proteoliposomes were dissolved with 0.1 % 
(v/v) Triton X-100 and the enzymatic activities of ArcA and ArcB were determined; control 
experiments showed that Triton X-100 had no effect on the enzymes or the COLDER assay. To 
determine the salt dependence of the enzymes, 50 mM KPi pH 7.0 was supplemented with 50 to 300 
mM of KCl or NaCl. Alternatively, the reaction mixture was composed of 50 to 300 mM of KPi, NaPi 
or Tris-HCl at pH 7.0.
Enzymatic assays for ArcC1. The activity of ArcC1 was obtained from changes in ATP/ADP ratio 
as measured with the ratiometric fluorescent protein PercevalHR [52], as described in [38], or by 
direct measurements of ATP with the ATPliteTM Luminescence Assay System (PerkinElmer, Inc.). 
For the ATP luminescence measurements, 0.25 µg mL-1 ArcC1 was incubated in 50 mM KPi, pH 7.0 
(buffer A) at 30 °C for 3 min, in a total volume of 275 µL. To start the reaction, 5 mM Mg-ADP plus 
5 mM carbamoyl-Pi were added and ATP formation was analyzed every 30 sec for up to 2.5 min. To 
stop the reaction, 50 µL of the mixture was pipetted into 50 µL of ATPliteTM mammalian cell lysis 
solution plus 50 µL of buffer A, which was present in each well of a 96-well flat-bottom white 
polystyrene plate (Greiner Bio-One International GmbH). Additionally, a set of calibration samples 
with Mg-ATP concentrations ranging from 0 to 0.5 mM was added to the ATPliteTM mammalian cell 
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of ATPliteTM substrate solution was added and the plate was shaken for another 5 min at 700 rpm. 
Next, the plate was dark adapted for 10 min before luminescence was read in a plate reader (BioTek 
Instruments, Inc.). Enzyme activity (in nmol Mg-ATP x min-1 x mg protein-1) was determined by 
equation 1 with the modification that Δcal is the slope of the calibration curve in AU x nmol Mg-ATP-
1.
For the experiments with ADI pathway intermediates, 0 to 10 mM of L-arginine, L-ornithine or L-
citrulline were added to the reaction mixtures. To determine the effects of pH, temperature, freeze-
thaw cycles, salt concentration and buffer composition, the same adjustments were made as described 
in the previous section for ArcA and ArcB.
Transport assays for ArcD2. The activity of ArcD2 was measured from the uptake of radiolabeled 
substrates, as described in [38], with some adjustments. Proteoliposomes with ArcD2 in the 
membrane at a protein-to-lipid ratio of 1:200 (w/w) (66 µL, 6.6 mg of lipid) were encapsulated with 
L-ornithine (0, 0.5, 1, 2, 3.5, 5 or 10 mM) or L-citrulline (0, 1, 2, 5, 10 or 20 mM) in buffer A with 5 
freeze-thaw cycles in a total volume of 200 µL. The proteoliposomes were extruded 13 times through 
a 200 nm pore size polycarbonate filter and diluted to 6 mL in buffer A with or without the same 
concentration of L-ornithine or L-citrulline as present on the inside. Proteoliposomes were collected 
by centrifugation (20 min, 225.000 x g, 4 °C), washed with buffer A (6 mL), centrifuged again and 
resuspended in 30 µL buffer A per 6.6 mg of lipid, yielding a final concentration of 220 mg of lipid x 
mL-1. For the transport assay, proteoliposomes were diluted 100-fold to a final concentration of 2.2 
mg of lipid x mL-1, in pre-heated (30 °C, 3 min) buffer A with 25 µM L-arginine [of which 4 % 
(mol/mol) was 14C-radiolabeled] and 100 µL samples were taken every 20 sec over an 80 sec period. 
After given reaction times, the samples were diluted into 2 mL of ice-cold buffer A and filtered over 
0.45 µm pore size cellulose nitrate filters to stop the uptake of amino acid. The filter was then washed 
with another 2 mL of buffer A. Radioactivity on the filter was quantified by liquid scintillation 
counting using Ultima Gold MV scintillation fluid (PerkinElmer) and a Tri-Carb 2800TR scintillation 
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50 mM NaPi, pH 7.0 (ΔΨ = -120 mV) instead of buffer A, supplemented with 1 µM of the potassium 
ionophore valinomycin. 
To determine the KM and VMAX values of arginine/ornithine and arginine/citrulline transport, the same 
protocol was used except that the external concentration of arginine or the internal concentration of 
ornithine or citrulline were varied. To determine the optimal reconstitution conditions, ArcD2-to-lipid 
ratios of 1:800 (w/w), 1:400 1:200 and 1:100 were used, and the proteoliposomes were filled with 10 
mM L-ornithine. To determine the lipid dependence of ArcD2, the protein was reconstituted into the 
lipid mixtures specified in Table 2; the proteoliposomes were filled with 10 mM L-ornithine and were 
assayed with 10 µM L-arginine on the outside [of which 10 % (mol/mol) was 14C-radiolabeled].
To determine the influx of arginine (without counter-substrate present on the inside), the 
proteoliposomes were filled with buffer A and frozen-thawed as described heretofore. 
Proteoliposomes were incubated in buffer A or 50 mM NaPi, pH 7.0 plus 1 µM valinomycin and were 
assayed with 1 µM 14C-L-arginine. Samples were taken every 10 to 15 min; the transport reactions 
were terminated and the vesicles were collected by ultrafiltration as described above. To determine 
the duration of the artificially-imposed membrane potential, proteoliposomes were filled with 10 mM 
L-citrulline and diluted in 50 mM NaPi, pH 7.0 with 1 µM valinomycin with or without 250 mM 
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Tables
Table 1. Properties of the proteins
Protein Monomeric molar 
extinction coefficient 
(M-1 cm-1)






ArcA 34,505 5.45 47.7 194 Tetramer
ArcB 36,900 5.78 40.9 245 Hexamer
ArcC1 21,430 5.08 36.2 73 Dimer
ArcD2 109,445 9.38 56.7 53 Monomer
Values for molar extinction coefficient, isoelectric point (pI) and monomeric molecular weight (MW) 
were calculated with ExPASy ProtParam. Native MW as observed with SEC-MALS (see Fig. 2B).
Table 2. Lipid compositions used in this study
Name DOPE DOPG DOPC
50 % DOPG 50 50 0
38 % DOPG 50 38 12
25 % DOPG 50 25 25
13 % DOPG 50 13 37
0 % DOPG 50 0 50
POPE POPG POPC
38 % POPG 50 38 12
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Figure legends
Figure 1. Schematic of the arginine breakdown pathway. AOA = arginine/ornithine antiporter, ADI = 
arginine deiminase, OTC = ornithine transcarbamoylase, CK = carbamate kinase.
Figure 2. SDS-PAGE and static light scattering analysis of proteins. (A) SDS-PAGE analysis of purified 
ArcA, ArcB, ArcC1 and ArcD2, of which the theoretical molecular weights of the monomers are 47.7, 40.9, 
36.2 and 56.7 kDa, respectively. Full gels are shown in Fig. 7. (B) SEC-MALS chromatograms of ArcA (top 
left), ArcB (top right), ArcC1 (bottom left) and ArcD2 (bottom right), showing refractive index (blue traces), 
light scattering (green traces) and absorption at 280 nm (pink traces). The peaks (yellow traces) indicate 
molecular weights of 194, 245, 73 and 53 kDa for native ArcA, ArcB, ArcC1 and ArcD2, respectively, which 
indicates that ArcA is tetrameric, ArcB is hexameric, ArcC1 is dimeric and ArcD2 is monomeric under native 
conditions. Additionally, the molecular weight of the DDM mass associated with ArcD2 is indicated and 
corresponds to 156 kDa. BSA and aldolase standards are shown in Fig. 8.
Figure 3. Arginine deiminase (ADI, ArcA) activity. Standard conditions are: 42 nM ArcA, 480 µM arginine 
in 50 mM KPi, pH 7.0 at 30 °C. Error bars represent the standard deviation between replicates, grey lines mark 
the activity of ArcA under standard conditions, which is normalized to 100 %. (A) Schematic of the ArcA 
reaction. Keq value was calculated with an ionic strength of 0.1 M at pH 7.0 using eQuilibrator 2.2. (B) 
Michaelis-Menten plot of ArcA activity versus arginine concentration, giving a KM of 34.5 ± 6.6 µM, a VMAX 
of 4.2 ± 0.2 µmol min-1 mg-1 and a kcat of 3.3 ± 0.2 s-1. Data from biological triplicates (n=3). (C) Substrate 
inhibition observed for ArcA at higher arginine concentrations, using 3.2 nM ArcA. Fitted with uncompetitive 
inhibition (see Materials & Methods) gives a KM of 5.8 ± 0.9 µM, a VMAX of 9.0 ± 0.4 µmol min-1 mg-1 and a KI 
of 3.2 ± 0.4 mM. Data from a single experiment (n=1). (D) Influence on ArcA activity of increasing amounts 
of ornithine (blue bars) and carbamoyl-Pi (green bars); data from biological duplicates (n=2), 100 % activity 
equals 4.5 µmol min-1 mg-1. (E) Influence on ArcA activity of pH (left), temperature (middle) and freeze-thaw 
(FT) cycles (right); data from biological duplicates (n=2), 100 % activity equals 4.2 µmol min-1 mg-1. (F) 
Influence on ArcA activity of different (concentrations of) salts, namely potassium phosphate (KPi; blue bars), 
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bars) and Tris-HCl (Tris; light blue bars). 50 mM KPi was added to all the KCl and NaCl measurements; data 
from biological duplicates (n=2), 100 % activity equals 5.0 µmol min-1 mg-1.
Figure 4. Ornithine transcarbamoylase (OTC, ArcB) activity. Standard conditions are: 1 nM ArcB, 5 mM 
ornithine and 5 mM carbamoyl-Pi in 50 mM KPi, pH 7.0 at 30 °C. Error bars represent the standard deviation 
between replicates, grey lines mark the activity of ArcB under standard conditions, which is normalized to 100 
%. (A) Schematic of the ornithine transcarbamoylase reaction in the direction of citrulline formation, which is 
opposite of how the reaction runs in the arginine breakdown pathway. Keq value was calculated with an ionic 
strength of 0.1 M at pH 7.0 using eQuilibrator 2.2. (B) Michaelis-Menten plot of ArcB activity versus ornithine 
(left) and carbamoyl-Pi (right) concentration. Fitting gives a KM of 0.7 ± 0.2 mM, a VMAX of 600 ± 40 µmol 
min-1 mg-1 and a kcat of 410 ± 30 s-1 when ornithine is varied and carbamoyl-Pi is kept at 5 mM. Additionally, a 
KM of 2.7 ± 0.4 mM, a VMAX of 830 ± 65 µmol min-1 mg-1 and a kcat of 565 ± 45 s-1 are obtained when 
carbamoyl-Pi is varied and ornithine is kept at 5 mM; data from biological duplicates (n=2). (C) Influence on 
ArcB activity of increasing amounts of arginine; data from biological duplicates (n=2), 100 % activity equals 
340 µmol min-1 mg-1. (D) Influence on ArcB activity of pH (left), temperature (middle) and freeze-thaw (FT) 
cycles (right).  Effect of FT cycles was studied for ArcB in solution (blue squares) and encapsulated in 
proteoliposomes (green circles); data from biological duplicates (n=2), 100 % activity equals 480 µmol min-1 
mg-1. (E) Influence on ArcB activity of different (concentrations of) salts. 10 mM KPi was added to all the KCl 
measurements; data from biological duplicates (n=2), 100 % activity equals 310 µmol min-1 mg-1.
Figure 5. Carbamate kinase (CK, ArcC1) activity. Standard conditions are: 46 nM ArcC1, 5 mM 
carbamoyl-Pi and 5 mM Mg-ADP in 50 mM KPi, pH 7.0 at 30 °C. Error bars represent the standard deviation 
between replicates, grey lines mark the activity of ArcC1 under standard conditions, which is normalized to 
100 %. (A) Schematic of the carbamate kinase reaction. Keq value was calculated with an ionic strength of 0.1 
M at pH 7.0 using eQuilibrator 2.2. (B) Michaelis-Menten plot of ArcC1 activity versus carbamoyl-Pi (left) 
and ADP (right) concentration. Fitting gives a KM of 0.6 ± 0.2 mM, a VMAX of 330 ± 30 µmol min-1 mg-1 and a 
kcat of 200 ± 20 s-1 when carbamoyl-Pi is varied and Mg-ADP is kept at 5 mM. A KM of 1.6 ± 0.7 mM, a VMAX 
of 310 ± 40 µmol min-1 mg-1 and a kcat of 190 ± 15 s-1 are obtained when Mg-ADP is varied and carbamoyl-Pi 
is kept at 5 mM; data from biological duplicates (n=2). (C) Influence on ArcC1 activity of increasing amounts 
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100 % activity equals 390 µmol min-1 mg-1. (D) Influence on ArcC1 activity of pH (left), temperature (middle) 
and freeze-thaw (FT) cycles (right); data from biological duplicates (n=2), 100 % activity equals 380 µmol 
min-1 mg-1. (E) Influence on ArcC1 activity of different (concentrations of) salts and buffers. 50 mM KPi was 
added to all the KCl and NaCl measurements; data from biological duplicates (n=2), 100 % activity equals 400 
µmol min-1 mg-1.
Figure 6. Arginine/ornithine antiporter (AOA, ArcD2) activity. Standard conditions are: 1:200 (w/w) 
ArcD2:lipid ratio, using 50:38:12 (w/w) DOPE:DOPG:DOPC lipids extruded through 200 nm polycarbonate 
filters; in transport assays: 176 nM ArcD2 plus 25 µM arginine externally and 10 mM ornithine or citrulline 
internally in 50 mM KPi, pH 7.0 at 30 °C. Error bars represent the standard deviation between replicates; grey 
lines mark the activity of ArcD2 under standard conditions, which is normalized to 100 %. (A) Schematic of 
the arginine/ornithine antiport reaction. (B) Michaelis-Menten plot of ArcD2 activity versus external arginine 
(left) and internal ornithine (right) concentration. Fitting gives a KM of 6.0 ± 0.7 µM, a VMAX of 120 ± 5 nmol 
min-1 mg-1 and a kcat of 0.11 ± 0.005 s-1 when external arginine is varied and internal ornithine is kept at 10 
mM. Additionally, a KM of 2.5 ± 0.7 mM, a VMAX of 95 ± 10 nmol min-1 mg-1 and a kcat of 0.09 ± 0.009 s-1 are 
obtained when ornithine is varied and arginine is kept at 25 µM. Arginine data from biological triplicates 
(n=3), ornithine data from technical duplicates (n=2). (C) Michaelis-Menten plot of ArcD2 activity versus 
internal citrulline concentration, with and without a membrane potential (ΔΨ) of -120 mV, giving a KM of 6.0 ± 
2.1 mM and a VMAX of 20 ± 3 nmol min-1 mg-1 for measurements in the presence of ΔΨ; data from technical 
duplicates (n=2). (D) Influence on ArcD2 activity of protein-to-lipid ratio (left), lipid headgroups (middle) and 
lipid tail types (right). Protein-to-lipid ratios range from 1:800 (w/w), to 1:400, 1:200 and 1:100. Lipid 
headgroups were varied from 50:50:0 (w/w) (DOPE:DOPG:DOPC) to 50:38:12, 50:25:25, 50:13:37 and 
50:0:50. The 50:38:12 lipid composition was studied with DO and PO acyl tails. Data from technical duplicates 
(n=2), with 10 mM ornithine internally; protein-to-lipid ratios data with 25 µM arginine externally; lipid 
headgroups and tail types data with 10 µM arginine externally; 100 % activity equals 120 nmol min-1 mg-1. (E) 
Influx of arginine into empty proteoliposomes, with and without a membrane potential (ΔΨ) of -120 mV. Inset: 
influx of arginine into proteoliposomes filled with 10 mM ornithine. Empty proteoliposomes data from single 
experiment (n=1); ornithine data from biological triplicates (n=3); with 1 µM arginine outside. (F) Initiation of 
the arginine/ornithine antiport reaction after different periods of imposing a membrane potential (ΔΨ) of -120 
mV, in the presence (blue squares) and absence (green circles) of an osmotic shock. Data from single 
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Figure 7. Full SDS-PAA gels showing the purification of ArcA, ArcB, ArcC1 and ArcD2. Molecular 
weight (MW) markers at 97, 66, 45, 30, 20 and 14 kDa. Cell lysate fractions equals raw cell lysate before 
purification, column flow through, and column wash fractions of the Ni2+-Sepharose resin purifications. Metal-
affinity and size-exclusion chromatography (SEC) purified fractions are also shown. (A) SDS-PAA gel for 
ArcA and ArcB. (B) SDS-PAA gel for ArcC1. (C) SDS-PAA gel for ArcD2.
Figure 8. Static light scattering chromatograms of BSA and aldolase. Static light scattering (SLS) 
chromatograms for bovine serum albumin (BSA; left) and aldolase (right), with refractive index (blue traces), 
light scattering (green traces) and absorption at 280 nm (pink traces). The molecular weight at the peaks 
(yellow traces) indicate 66 and 157 kDa for BSA and aldolase, respectively. BSA was used as a standard 
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